Jessica Vincent

发表

Drop-The-Loser: A practical bayesian adaptive design for a clinical trial of citalopram for cocaine use disorder

F. Moeller, J. Schmitz, C. Green, 2017 .

PPAR‐gamma agonist pioglitazone modifies craving intensity and brain white matter integrity in patients with primary cocaine use disorder: a double‐blind randomized controlled pilot trial

K. Hasan, P. Narayana, F. Moeller, 2017, Addiction.

Preliminary examination of the orexin system on relapse-related factors in cocaine use disorder

S. Lane, J. H. Yoon, J. Schmitz, 2020, Brain Research.

A sequential multiple assignment randomized trial for cocaine cessation and relapse prevention: Tailoring treatment to the individual.

J. H. Yoon, A. Stotts, J. Schmitz, 2018, Contemporary clinical trials.

Baseline cocaine demand predicts contingency management treatment outcomes for cocaine-use disorder.

S. Lane, J. H. Yoon, A. Stotts, 2020, Psychology of addictive behaviors : journal of the Society of Psychologists in Addictive Behaviors.

Elevated Neutrophil to Lymphocyte Ratio in Older Adults with Cocaine Use Disorder as a Marker of Chronic Inflammation

S. Lane, M. Wardle, J. Schmitz, 2020, Clinical psychopharmacology and neuroscience : the official scientific journal of the Korean College of Neuropsychopharmacology.

Citalopram for treatment of cocaine use disorder: A Bayesian drop-the-loser randomized clinical trial.

S. Lane, J. Schmitz, C. Green, 2021, Drug and alcohol dependence.

Decreased cocaine demand following contingency management treatment.

S. Lane, J. H. Yoon, J. Schmitz, 2021, Drug and alcohol dependence.

The effects of combination levodopa-ropinirole on cognitive improvement and treatment outcome in individuals with cocaine use disorder: A bayesian mediation analysis.

S. Lane, J. Schmitz, C. Green, 2021, Drug and alcohol dependence.

Anhedonia Is Associated with Poorer Outcomes in Contingency Management for Cocaine Use Disorder.

S. Lane, M. Wardle, J. Schmitz, 2017, Journal of substance abuse treatment.

Using a data science approach to predict cocaine use frequency from depressive symptoms.

S. Lane, M. Wardle, J. Schmitz, 2019, Drug and alcohol dependence.

Initial development of a brief assessment of cocaine demand.

S. Lane, J. Schmitz, R. Suchting, 2020, Behavioural pharmacology.

Cocaine-specific speed-accuracy trade-off during anti-saccade testing differentiates patients with cocaine use disorder who achieve initial abstinence during treatment

S. Lane, A. Stotts, J. Schmitz, 2021, Journal of psychopharmacology.